Bioretec Revises Financial Targets
Bioretec Ltd announced that it is revising its financial targets and deems that the current targets will not be met, thus withdrawing them.
On September 12, 2025, the company stated that the revised timeline for the commercialization of DrillPin in the U.S. was not expected to have a material effect on its financial targets published on October 4, 2024.
Bioretec is currently assessing and updating its overall commercialization strategy and pipeline, with an update expected by the end of 2025.
The company will provide an update by the end of 2025.
Author's summary: Bioretec revises financial targets due to commercialization delays.